Aldeyra Therapeutics (ALDX) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Aldeyra Therapeutics (ALDX) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 1,378.45% |
| 10 | Aldeyra Therapeutics | 93.49 Mn | 93.49 Mn | - | -491.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -491.83% |
| Dec 31, 2025 | 73.23% |
| Sep 30, 2025 | 46.23% |
| Jun 30, 2025 | 77.37% |
| Mar 31, 2025 | 93.21% |
| Dec 31, 2024 | -418.01% |
| Sep 30, 2024 | -72.22% |
| Jun 30, 2024 | -6,279.56% |
| Mar 31, 2024 | -2,857.69% |
| Dec 31, 2023 | 60.81% |
| Sep 30, 2023 | 57.98% |
| Jun 30, 2023 | 94.66% |
| Mar 31, 2023 | 91.50% |
| Dec 31, 2022 | 8.73% |
| Sep 30, 2022 | -134.56% |
| Jun 30, 2022 | -1,523.83% |
| Mar 31, 2022 | -1,545.20% |
| Dec 31, 2021 | 8.69% |
| Sep 30, 2021 | -44.80% |
| Jun 30, 2021 | 83.85% |